2022 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦5ȸ µ¿°èÇмú´ëȸ : 2022-01-23 |
|
2022 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦5ȸ µ¿°èÇмú´ëȸ : 2022-01-23 ±³À°ÀÏÀÚ : 2022-01-23 ±³À°Àå¼Ò : ÄÜ·¡µå È£ÅÚ, 5Ãþ ÆÄÅ©º¼·Ò ±³À°ÁÖÁ¦ : 2022 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦5ȸ µ¿°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ´ã´çÀÚ : Á¤¼Ò¿µ ¿¬¶ôó : 02-512-5915 À̸ÞÀÏ : office@sgo.or.kr ±³À°Á¾·ù : »êºÎÀΰú Âü¼®¿¹»óÀοø : 150¸í Èñ¸ÁÆòÁ¡ : 4Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ ¼¼ºÎ¼ö°·á : 30,000¿ø ºñ°í Àü¹®ÀÇ 30,000 Àü°øÀÇ,ÀϹÝÀÇ,¿¬±¸¿ø,°£È£»ç 20,000 ÁÂÀå,¿¬ÀÚ,¸¸65¼¼ÀÌ»ó ¹«·á ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±âŸ 01-23 ÆÄÅ©º¼·Ò 09:30~09:50 Registration () ±âŸ 01-23 ÆÄÅ©º¼·Ò 09:50~10:00 Opening Remarks ±è¿µÅÂ(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 10:00~10:20 New recommendations for screening and treatment to prevent cervical cancer (WHO guidelines) À̼ºÁ¾(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 10:20~10:40 Cervical screening: position status of the European Society of Gynecologic Oncology (ESGO) ÁÖ¿õ(ÀÌÈÀÇ´ë) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 10:40~11:00 Discussion ¹ÚÁ¤¿/Á¤´ëÈÆ/Á¶Çö¿õ(¿ï»êÀÇ´ë/ÀÎÁ¦ÀÇ´ë/°í·ÁÀÇ´ë) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 11:00~11:25 Current Status of Cervical Cancer Screening in Japan Aikou Okamoto(The Jikei University School of Medicine Japan)) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 11:25~11:30 Discussion ½É½ÂÇõ(°Ç±¹ÀÇ´ë) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 11:30~11:55 Newly launched Swedish HPV and screening guidelines Jan Persson(Skane University Sweden) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 11:55~12:00 Discussion À¯»ó¿µ(¿øÀڷº´¿ø) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 12:00~12:20 Challenges of introducing HPV DNA test into an established opportunistic cervical cancer screening program. The singapore experience Ida Ismail-Pratt(Mount Elizabeth Novena HospitalSingapore) ½Ä»ç 01-23 ÆÄÅ©º¼·Ò 12:20~13:30 Lunch () ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 13:30~13:55 Role of HPV Test in Cervical Cytology ÀüÀÌ°æ(°í·ÁÀÇ´ë º´¸®ÇÐ) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 13:55~14:20 Currently applicable HPV Tests ¹ÚÀºÇâ(¿¬¼¼ÀÇ´ë º´¸®ÇÐ) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 14:20~14:35 Discussion ÀÌÁ¤¿ø/À̱ÙÈ£/±è»ó¿î(¼º±Õ°üÀÇ´ë/°¡Å縯ÀÇ´ë/¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 14:35~14:55 National cervical cancer screening program (Korea) ÀÌÀç°ü(°í·ÁÀÇ´ë) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 14:55~15:15 Clinical relevance of the HPV vaccine in women already infected with HPV ½Å¼ÒÁø(°è¸íÀÇ´ë) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 15:15~15:30 Discussion Á¶ÇѺ°/±è¹Î±Ô/ÀÌ¿ø¹«(¿¬¼¼ÀÇ´ë/¼º±Õ°üÀÇ´ë/ÇѾçÀÇ´ë) ÈÞ½Ä 01-23 ÆÄÅ©º¼·Ò 15:30~15:50 Coffee Break () ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 15:50~16:10 Pitfall of imaging studies for FIGO staging by PET ÀüÅÂÁÖ(¿¬¼¼ÀÇ´ë ÇÙÀÇÇаú) ±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 16:10~16:30 Current HPV status around the world ÀÓ°¡¿ø(µ¿±¹ÀÇ´ë) Åä·Ð 01-23 ÆÄÅ©º¼·Ò 16:30~16:45 Discussion ÀÓ¸íö/°øÅ¿í/¼Ò°æ¾Æ(±¹¸³¾Ï¼¾ÅÍ/¾ÆÁÖÀÇ´ë/°Ç±¹ÀÇ´ë) ±âŸ 01-23 ÆÄÅ©º¼·Ò 16:45~16:50 Closing Remarks () |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|